NL-OMON45696
Completed
Phase 4
The antibody response to pneumococcal vaccination in patients with inflammatory bowel disease patients treated with immunosuppressive agents - PNEUMOREACT
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- antibody response
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 178
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Age \> 18 years old
- •\- On treatment with an immunosuppressive agent or planned treatment start with a TNF\-alpha inhibitor within 3 months after recruitment
- •\- Indication for pneumococcal vaccination (PCV13 plus PPV23\)
- •\- Able to give informed consent
- •\- Control group: diagnosed with IBD, not treated with immunosuppressives.
Exclusion Criteria
- •\- Diagnosis of an immune deficiency disorder
- •\- Age \< 18 years
- •\- Control group: treatment with immunosuppressive drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Immune response test as new predictor for successful TKI stop in patients with chronic myeloid leukemiaChronic myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10009016Term: Chronic myeloid leukemia in remissionSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10009015Term: Chronic myeloid leukemiaSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2020-002850-26-NLAlbert Schweitzer Hospital57
Recruiting
Not Applicable
Vaccination response to pneumococcal antigen as novel predictor for successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.NL-OMON55091Albert Schweitzer Ziekenhuis57
Recruiting
Not Applicable
De antistof respons na pneumokokkenvaccinatie bij IBD-patiënten die behandeld worden met immunosuppressiva – de PNEUMOREACT studieinflammatory bowel disease (inflammatoire darmziekte)immunosuppressive agents (immunosuppressiva)pneumococcal vaccination (pneumokokkenvaccinatie)vaccine immunogenicity (vaccin immunogeniciteit)NL-OMON29135Academic Medical Center188
Completed
Phase 2
Antibody Response to Pneumococcal Vaccines PPV and PCV in Beta Thalassemia Major without SpleeBeta Thalassemia Major.Beta thalassaemiaIRCT201110116660N3Mazandaran University of Medical Sciences50
Active, not recruiting
Not Applicable
Serological response to antipneumococcal vaccination and consequent impact on Streptococcus pneumoniae nasal carriage in HIV positive adultsHIV positive adults with out previous PPV23 or PCV7 vaccinationMedDRA version: 14.1Level: LLTClassification code 10035652Term: Pneumococcus infection in conditions classified elsewhere and of unspecified siteSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2011-004518-40-ITAZIENDA OSPEDALIERA SENESE